SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kopran - Quaterly Results

27 Oct 2021 Evaluate
The company witnessed a 19.44% growth in the revenue at Rs. 562.25 millions for the quarter ended September 2021 as compared to Rs. 470.73 millions during the year-ago period.Net profit of the cmpany stood at Rs. 37.76 millions for the quarter ended September 2021 a decline of -49.57% from Rs. 74.88 millions  in the same quarter last year.Operating Profit reported a sharp decline to 65.72 millions from 126.69 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 562.25 470.73 19.44 854.45 1043.06 -18.08 2228.33 1792.91 24.29
Other Income 19.72 32.64 -39.58 43.23 56.59 -23.61 104.14 19.90 423.32
PBIDT 65.72 126.69 -48.13 94.45 235.09 -59.82 406.14 251.66 61.38
Interest 5.26 11.15 -52.83 11.81 25.72 -54.08 38.07 59.62 -36.15
PBDT 60.46 115.54 -47.67 82.64 209.37 -60.53 368.07 192.04 91.66
Depreciation 10.88 10.49 3.72 21.65 20.05 7.98 41.03 34.72 18.17
PBT 49.58 105.05 -52.80 60.99 189.32 -67.78 327.04 157.32 107.88
TAX 11.82 30.17 -60.82 14.52 54.24 -73.23 92.33 45.13 104.59
Deferred Tax 3.05 11.72 -73.98 3.76 21.27 -82.32 34.76 17.12 103.04
PAT 37.76 74.88 -49.57 46.47 135.08 -65.60 234.71 112.19 109.21
Equity 432.52 432.49 0.01 432.52 432.49 0.01 432.52 432.49 0.01
PBIDTM(%) 11.69 26.91 -56.57 11.05 22.54 -50.96 18.23 14.04 29.85

Kopran Share Price

159.60 4.70 (3.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×